Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling

被引:53
作者
Gosu, Vijayakumar [1 ]
Basith, Shaherin [1 ]
Kwon, O-Pil [1 ]
Choi, Sangdun [1 ]
机构
[1] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea
基金
新加坡国家研究基金会;
关键词
Toll-like receptor; nucleic acid analogues; cancer; autoimmune disease; viral infection; clinical status; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNE-RESPONSE MODIFIERS; PATTERN-RECOGNITION RECEPTORS; PLASMACYTOID DENDRITIC CELLS; DOUBLE-STRANDED-RNA; ACTIVATE B-CELLS; PATHOGEN RECOGNITION; CYTOKINE INDUCTION; INNATE IMMUNITY; BACTERIAL-DNA;
D O I
10.3390/molecules171113503
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) belong to a family of innate immune receptors that detect and clear invading microbial pathogens. Specifically intracellular TLRs such as TLR3, TLR7, TLR8 and TLR9 recognize nucleic acids such as double-stranded RNA, single-stranded RNA and CpG DNA respectively derived from microbial components. Upon infection, nucleic acid sensing TLRs signal within endosomal compartment triggering the induction of essential proinflammatory cytokines and type I interferons to initiate innate immune responses thereby leading to a critical role in the development of adaptive immune responses. Thus, stimulation of TLRs by nucleic acids is a promising area of research for the development of novel therapeutic strategies against pathogenic infection, allergies, malignant neoplasms and autoimmunity. This review summarizes the therapeutic applications of nucleic acids or nucleic acid analogues through the modulation of TLR signaling pathways.
引用
收藏
页码:13503 / 13529
页数:27
相关论文
共 155 条
[1]   Synthetic agonists of Toll-like receptors 7, 8 and 9 [J].
Agrawal, S. ;
Kandimalla, E. R. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :1461-1467
[2]   Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells [J].
Akazawa, Takashi ;
Ebihara, Takashi ;
Okuno, Manabu ;
Okuda, Yu ;
Shingai, Masashi ;
Tsujimura, Kunio ;
Takahashi, Toshitada ;
Ikawa, Masahito ;
Okabe, Masaru ;
Inoue, Norimitsu ;
Okamoto-Tanaka, Miki ;
Ishizaki, Hiroyoshi ;
Miyoshi, Jun ;
Matsumoto, Misako ;
Seya, Tsukasa .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) :252-257
[3]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[4]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[5]   Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis [J].
Asagiri, Masataka ;
Hirai, Toshitake ;
Kunigami, Toshihiro ;
Kamano, Shunya ;
Gober, Hans-Juergen ;
Okamoto, Kazuo ;
Nishikawa, Keizo ;
Latz, Eicke ;
Golenbock, Douglas T. ;
Aoki, Kazuhiro ;
Ohya, Keiichi ;
Imai, Yuuki ;
Morishita, Yasuyuki ;
Miyazono, Kohei ;
Kato, Shigeaki ;
Saftig, Paul ;
Takayanagi, Hiroshi .
SCIENCE, 2008, 319 (5863) :624-627
[6]   TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity [J].
Baccala, Roberto ;
Hoebe, Kasper ;
Kono, Dwight H. ;
Beutler, Bruce ;
Theofilopoulos, Argyrios N. .
NATURE MEDICINE, 2007, 13 (05) :543-551
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   Treatment of lupus-prone of TLR7 and TLR9 leads to mice with a dual inhibitor reduction of autoantibody production and amelioration of disease symptoms [J].
Barrat, Franck J. ;
Meeker, Thea ;
Chan, Jean H. ;
Guiducci, Cristiana ;
Cofftnan, Robert L. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (12) :3582-3586
[9]   Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy [J].
Barry, Mazin ;
Cooper, Curtis .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) :1731-1737
[10]   Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA [J].
Barton, GM ;
Kagan, JC ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2006, 7 (01) :49-56